Author

J. Nickerson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Dunn· 1 shared A. Hamel· 1 shared A. Imbalzano· 1 shared A. J. Coyle· 1 shared A. K. Shalek· 1 shared A. Moarefi· 1 shared A. Sheen· 1 shared A. W. Goldrath· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Dunn

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Age-related RPE Changes in Wildtype C57BL/6J Mice Between 2 and 32 Months

D. A. Shelton, I. Gefke, K. Liao, V. Summers, H. Yu, Y.-K. Kim, Y. Getz, S. Ferdous, K. Donaldson, J. Papania, M. Chrenek, J. Boatright, J. Nickerson

This study evaluates age-related changes in RPE structure and function in C57BL/6J mice, finding increased alpha-catenin expression and immune cell recruitment in aged mice.

bioRxiv · Jan 30, 2024 · PreprintCell Biology

Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8+ T cell repertoire upon viral exposure

J. M. Francis, D. Leistritz-Edwards, A. Dunn, C. Tarr, J. Lehman, C. Dempsey, A. Hamel, V. Rayon, G. Liu, Y. Wang, M. Wille, M. Durkin, K. Hadley, A. Sheen, B. Roscoe, , D. C. Pregibon

The paper characterizes CD8+ T cell responses to SARS-CoV-2 across HLA alleles, showing HLA genotype influences pre-existing immunity and immune repertoire upon viral exposure.

bioRxiv · Apr 29, 2021 · PreprintImmunology

BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer

R. Muthuswami, L. Bailey, R. Rakesh, A. Imbalzano, J. Nickerson, J. W. Hockensmith

This study shows BRG1 is elevated in prostate tumors and correlates with poor survival, and a BRG1 inhibitor reduces tumor growth and improves survival in xenograft models.

bioRxiv · Dec 27, 2018Cancer Biology